Literature DB >> 32366088

Metal-Assisted Protein Quantitation (MAPq): Multiplex Analysis of Protein Expression Using Lanthanide-Modified Antibodies with Detection by Inductively Coupled Plasma Mass Spectrometry.

Sarah C Shuck, Cu Nguyen, Yin Chan, Timothy O'Connor, Alexandra K Ciminera, Michael Kahn, John Termini.   

Abstract

Understanding the complex relationships between genomics, transcriptomics, and proteomics requires the development of more sensitive and rapid methods of multiplexed protein analysis. This is necessary to understand the relationship between cellular responses to environmental stresses, disease progression, and/or drug treatment; however, most methods are limited by low sensitivity, nonspecificity, and minimal multiplexing capacity. To more fully explore the relationship between multiple cellular pathways, we have developed a novel antibody-based multiplex assay using inductively coupled plasma mass spectrometry (ICP-MS), which we term metal-assisted protein quantitation (MAPq). MAPq utilizes lanthanide-conjugated antibodies to simultaneously quantify up to 35 proteins with low pg/mL sensitivity. This method is especially advantageous for low-abundance proteins, a significant limitation of many multiplex MS methods. We observed a limit of detection of 0.5 pg/mL and a limit of quantitation of 5 pg/mL with virtually no background signal. We applied this method to both cultured cells and mouse tissues to investigate changes in low-abundance nuclear and cytoplasmic proteins following drug or environmental stresses. MAPq was found to be at least 10 times more sensitive than Western blots and could detect quantitative changes in protein expression not readily observed using conventional approaches.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32366088      PMCID: PMC9126136          DOI: 10.1021/acs.analchem.0c00058

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   8.008


  53 in total

Review 1.  Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine.

Authors:  Andrea D Weston; Leroy Hood
Journal:  J Proteome Res       Date:  2004 Mar-Apr       Impact factor: 4.466

2.  Linking genome and proteome by mass spectrometry: large-scale identification of yeast proteins from two dimensional gels.

Authors:  A Shevchenko; O N Jensen; A V Podtelejnikov; F Sagliocco; M Wilm; O Vorm; P Mortensen; A Shevchenko; H Boucherie; M Mann
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

3.  ICP-MS analysis of lanthanide-doped nanoparticles as a non-radiative, multiplex approach to quantify biodistribution and blood clearance.

Authors:  Samuel H Crayton; Drew R Elias; Ajlan Al Zaki; Zhiliang Cheng; Andrew Tsourkas
Journal:  Biomaterials       Date:  2011-11-17       Impact factor: 12.479

4.  Antitumour activity of S-p-bromobenzylglutathione cyclopentyl diester in vitro and in vivo. Inhibition of glyoxalase I and induction of apoptosis.

Authors:  P J Thornalley; L G Edwards; Y Kang; C Wyatt; N Davies; M J Ladan; J Double
Journal:  Biochem Pharmacol       Date:  1996-05-17       Impact factor: 5.858

5.  Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors.

Authors:  Austin Gurney; Fumiko Axelrod; Christopher J Bond; Jennifer Cain; Cecile Chartier; Lucas Donigan; Marcus Fischer; Aurélie Chaudhari; May Ji; Ann M Kapoun; Andrew Lam; Sasha Lazetic; Shirley Ma; Satyajit Mitra; In-Kyung Park; Kellie Pickell; Aaron Sato; Sanjeev Satyal; Michelle Stroud; Hoang Tran; Wan-Ching Yen; John Lewicki; Timothy Hoey
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-02       Impact factor: 11.205

Review 6.  Antibody-based protein multiplex platforms: technical and operational challenges.

Authors:  Allison A Ellington; Iftikhar J Kullo; Kent R Bailey; George G Klee
Journal:  Clin Chem       Date:  2009-12-03       Impact factor: 8.327

7.  DNA damage and repair in type 2 diabetes mellitus.

Authors:  Janusz Blasiak; Michal Arabski; Renata Krupa; Katarzyna Wozniak; Marek Zadrozny; Jacek Kasznicki; Monika Zurawska; Jozef Drzewoski
Journal:  Mutat Res       Date:  2004-10-04       Impact factor: 2.433

8.  Oncogenic function of ATDC in pancreatic cancer through Wnt pathway activation and beta-catenin stabilization.

Authors:  Lidong Wang; David G Heidt; Cheong J Lee; Huibin Yang; Craig D Logsdon; Lizhi Zhang; Eric R Fearon; Mats Ljungman; Diane M Simeone
Journal:  Cancer Cell       Date:  2009-03-03       Impact factor: 31.743

9.  The chaperone-dependent ubiquitin ligase CHIP targets HIF-1α for degradation in the presence of methylglyoxal.

Authors:  Carla Figueira Bento; Rosa Fernandes; José Ramalho; Carla Marques; Fu Shang; Allen Taylor; Paulo Pereira
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

10.  Differentiation Therapy Targeting the β-Catenin/CBP Interaction in Pancreatic Cancer.

Authors:  Philipp Manegold; Keane K Y Lai; Yongfeng Wu; Jia-Ling Teo; Heinz-Josef Lenz; Yuri S Genyk; Stephen J Pandol; Kaijin Wu; David P Lin; Yibu Chen; Cu Nguyen; Yi Zhao; Michael Kahn
Journal:  Cancers (Basel)       Date:  2018-03-29       Impact factor: 6.639

View more
  1 in total

1.  Elevated glucose increases genomic instability by inhibiting nucleotide excision repair.

Authors:  Alexandra K Ciminera; Sarah C Shuck; John Termini
Journal:  Life Sci Alliance       Date:  2021-08-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.